Trastuzumab Biosimilar Antibody, Research Grade (Anti-Her2 / ErbB2)

Trastuzumab Biosimilar Antibody, Research Grade (Anti-Her2 / ErbB2) is a research-use monoclonal antibody designed to bind human Her2, also known as ErbB2, CD340 or HER-2/neu. Her2/ErbB2 is a receptor tyrosine kinase and an important oncology research target, particularly in studies of breast cancer, gastric cancer and other Her2-positive tumour models. This antibody is based on the binding specificity of trastuzumab and is intended for laboratory research applications involving Her2/ErbB2 detection, assay development, antibody comparison, biosimilar research and related in vitro studies. It may be useful as a reference-style anti-Her2 antibody in workflows such as ELISA, flow cytometry or other validated immunoassay formats, depending on the user’s own optimisation and experimental conditions. This product is supplied for research use only. It is not intended for therapeutic, diagnostic or clinical use.